Richard J. Poulton net worth and biography

Richard Poulton Biography and Net Worth

CFO of Veradigm

As president of Allscripts, Rick Poulton is responsible for day-to-day operations of all business units. Rick initially joined Allscripts in 2012 as chief financial officer to oversee the company’s financial operations, business development and strategy.

Rick served as the chief financial officer and treasurer for AAR Corp. after joining the company in 2006 as vice president of acquisitions and strategic investment. He spent more than ten years at UAL Corporation in progressively more senior financial and business development roles, including senior vice president of business development as well as president and CFO of the company's loyalty services subsidiary. He also served as vice president of finance for online retailer Ourhouse.com. Rick began his career in the audit practice of Arthur Andersen & Co., LLP, where he held multiple increasingly responsible positions.

Rick has served on the board of the Juvenile Diabetes Research Foundation. He holds a Bachelor of Science degree in accounting, with honors, from Marquette University and a Master of Business Administration, with concentrations in strategy and finance, from Northwestern University’s Kellogg Graduate School of Management.

What is Richard J. Poulton's net worth?: The estimated net worth of Richard J. Poulton is at least $6.86 million as of November 15th, 2022. Mr. Poulton owns 722,517 shares of Veradigm stock worth more than $6,863,912 as of December 21st. This net worth approximation does not reflect any other assets that Mr. Poulton may own. Learn More about Richard J. Poulton's net worth.
How do I contact Richard J. Poulton?: The corporate mailing address for Mr. Poulton and other Veradigm executives is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. Veradigm can also be reached via phone at (800) 334-8534 and via email at [email protected]. Learn More on Richard J. Poulton's contact information.
Has Richard J. Poulton been buying or selling shares of Veradigm?: Richard J. Poulton has not been actively trading shares of Veradigm in the last ninety days. Most recently, Richard J. Poulton sold 10,000 shares of the business's stock in a transaction on Tuesday, November 15th. The shares were sold at an average price of $18.14, for a transaction totalling $181,400.00. Following the completion of the sale, the chief executive officer now directly owns 722,517 shares of the company's stock, valued at $13,106,458.38. Learn More on Richard J. Poulton's trading history.
Who are Veradigm's active insiders?: Veradigm's insider roster includes Elizabeth Altman (Director), Paul Black (CEO), Greg Garrison (Director), Lisa Khorey (Insider), Michael Klayko (Director), and Richard Poulton (CFO). Learn More on Veradigm's active insiders.

Richard J. Poulton Insider Trading History at Veradigm

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/15/2022	Sell	10,000	$18.14	$181,400.00	722,517
8/15/2022	Sell	10,000	$17.46	$174,600.00	742,517
5/16/2022	Sell	10,000	$17.94	$179,400.00	761,674
2/15/2022	Sell	10,000	$20.83	$208,300.00
11/15/2021	Sell	10,000	$16.38	$163,800.00
3/5/2020	Buy	15,000	$7.22	$108,300.00
12/13/2018	Sell	60,000	$9.82	$589,200.00	479,520
6/15/2018	Sell	15,000	$12.40	$186,000.00
3/15/2018	Sell	15,000	$13.53	$202,950.00	505,920
12/15/2017	Sell	15,000	$14.26	$213,900.00	1,351,773
9/15/2017	Sell	15,000	$13.56	$203,400.00
5/16/2017	Sell	25,000	$12.06	$301,500.00	412,488
6/13/2016	Sell	10,000	$13.03	$130,300.00	343,813
3/14/2016	Sell	5,000	$12.85	$64,250.00	359,064
11/11/2014	Buy	4,500	$11.26	$50,670.00

Richard J. Poulton Buying and Selling Activity at Veradigm

Veradigm Company Overview

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Today's Range

Now: $9.50

$9.50

$9.52

50 Day Range

MA: $9.98

$9.00

$11.30

2 Week Range

Now: $9.50

$5.01

$11.80

Volume

160,761 shs

Average Volume

1,475,412 shs

Market Capitalization

$1.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW